Revenue ($USD) : $3,228,538,627
Revenue (foreign currencies) : JP¥453,610,000,000
R&D spend : $621,351,871
Employees : not available
Fiscal year end : 3/31/2024
CEO : Yoshihiko Sano

www.nipro.com

Nipro offers medical devices across five areas: renal products, interventional catheter-delivered products, hospital products, cardiopulmonary products and enzymes. The company is one of the leading manufacturers of dialyzers globally. It also reports continuing results with artificial organs and in the new area of tissue engineering. –CN